Genetic variants in N6-methyladenosine are associated with bladder cancer risk in the Chinese population

  • PDF / 2,203,618 Bytes
  • 11 Pages / 595.276 x 790.866 pts Page_size
  • 36 Downloads / 231 Views

DOWNLOAD

REPORT


GENOTOXICITY AND CARCINOGENICITY

Genetic variants in N6‑methyladenosine are associated with bladder cancer risk in the Chinese population Hanting Liu1,2 · Jingjing Gu1,2 · Yu Jin3 · Qi Yuan1,2 · Gaoxiang Ma1,2,4 · Mulong Du1,2 · Yuqiu Ge1,2 · Chao Qin5 · Qiang Lv5 · Guangbo Fu6 · Meilin Wang1,2 · Haiyan Chu1,2 · Lin Yuan7 · Zhengdong Zhang1,2  Received: 4 May 2020 / Accepted: 10 September 2020 © Springer-Verlag GmbH Germany, part of Springer Nature 2020

Abstract Recently ­N6-Methyladenosine ­(m6A) has been identified to guide the interaction of RNA-binding protein hnRNP C and their target RNAs, which is termed as ­m6A-switches. We systematically investigated the association between genetic variants in m ­ 6A-switches and bladder cancer risk. A two-stage case–control study was performed to systematically calculate the association of single nucleotide polymorphisms (SNPs) in 2798 ­m6A-switches with bladder cancer risk in 3,997 subjects. A logistic regression model was used to assess the effects of SNPs on bladder cancer risk. A series of experiments were adopted to explore the role of genetic variants of m ­ 6A-switches. We identified that rs5746136 (G > A) of SOD2 in m ­ 6A-switches was significantly associated with the reduced risk of bladder cancer (additive model in discovery stage: OR = 0.80, 95% CI 0.69–0.93, P = 3.6 × 10−3; validation stage: adjusted OR = 0.88, 95% CI 0.79–0.99, P = 3.0 × 10−2; combined analysis: adjusted OR = 0.85, 95% CI 0.78–0.93, P = 4.0 × 10−4). The mRNA level of SOD2 was remarkably lower in bladder cancer tissues than the paired adjacent samples. SNP rs5746136 may affect ­m6A modification and regulate SOD2 expression by guiding the binding of hnRNP C to SOD2, which played a critical tumor suppressor role in bladder cancer cells by promoting cell apoptosis and inhibiting proliferation, migration and invasion. In conclusion, our findings suggest the important role of genetic variants in ­m6A modification. SOD2 polymorphisms may influence the expression of SOD2 via an ­m6A-hnRNP C-dependent mechanism and be promising predictors of bladder cancer risk. Keywords N6-methyladenosine · Bladder cancer · Susceptibility · Molecular epidemiology

Hanting Liu, Jingjing Gu and Yu Jin contributed equally to this work. Electronic supplementary material  The online version of this article (https​://doi.org/10.1007/s0020​4-020-02911​-2) contains supplementary material, which is available to authorized users.

Abbreviations SNP Single nucleotide polymorphism GWAS Genome-wide association study m6A N6-Methyladenosine RBP RNA-binding proteins MAF Minor allele frequency

* Haiyan Chu [email protected]

for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China

* Lin Yuan [email protected]

3



Department of Laboratory Medicine, School of Public Health, Nantong University, Nantong, China

* Zhengdong Zhang [email protected]

4



The Clinical Metabolomics Center, China Pharmaceutical University, Nanjing, Jiangsu, China

5



Department of Urology, The First